Sign in to continue:

Thursday, April 30th, 2026

Author: Minichart

Halozyme Therapeutics Appoints Darren Snellgrove as Chief Financial Officer in April 2026

Halozyme Appoints New CFO: Key Details for Investors Hal...

LCNB CORP. Files Form 8-K with SEC Detailing Corporate Information and No Material Events – April 2026

LCNB Corp. Announces Results of Annual Shareholder Meeting -...

Twin Vee PowerCats Announces 1-for-37 Reverse Stock Split to Regain Nasdaq Compliance

Twin Vee PowerCats Co. Announces 1-for-37 Reverse Stock Spli...

NeuroOne Medical Technologies Announces CFO Transition and Release Agreement Filing

NeuroOne Medical Technologies Corporation - Form 8-K Detaile...

Join Our Investing Seminar

Limited seats available — Reserve your spot today